Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon W Hayward

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|January 25, 2005
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic developmentGerald R Cunha, Will Ricke, Axel Thomson, et al.
The Prostate|October 30, 2018
Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patientsTakeshi Sasaki, Omar E Franco, Kohshi Ohishi, et al.
Journal of Cell Science|May 25, 2018
PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblastsFrancesca Nardi, Philip Fitchev, Omar E Franco, et al.
Cancer Research|February 10, 2011
Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesisOmar E Franco, Ming Jiang, Douglas W Strand, et al.
Cancer Research|August 27, 2009
The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approachDavid Basanta, Douglas W Strand, Ralf B Lukner, et al.
Cancer Research|March 30, 2011
Role for stromal heterogeneity in prostate tumorigenesisMaria A Kiskowski, Roger S Jackson, Jheelam Banerjee, et al.
Oncotarget|September 10, 2016
Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivoShu Yang, Ming Jiang, Magdalena M Grabowska, et al.
Cancer Research|November 17, 2005
Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancerMargaret S Joesting, Steve Perrin, Brian Elenbaas, et al.
The Journal of Urology|January 16, 2007
A preliminary study of JM-27: a serum marker that can specifically identify men with symptomatic benign prostatic hyperplasiaGrant W Cannon, Chris Mullins, M Scott Lucia, et al.
The Prostate|September 3, 2010
Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epitheliaBrigid Orr, Griet Vanpoucke, O Cathal Grace, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Steroid Biochemistry and Molecular Biology|January 25, 2005
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic developmentGerald R Cunha, Will Ricke, Axel Thomson, et al.
The Prostate|October 30, 2018
Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patientsTakeshi Sasaki, Omar E Franco, Kohshi Ohishi, et al.
Journal of Cell Science|May 25, 2018
PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblastsFrancesca Nardi, Philip Fitchev, Omar E Franco, et al.
Cancer Research|February 10, 2011
Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesisOmar E Franco, Ming Jiang, Douglas W Strand, et al.
Cancer Research|August 27, 2009
The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approachDavid Basanta, Douglas W Strand, Ralf B Lukner, et al.
Cancer Research|March 30, 2011
Role for stromal heterogeneity in prostate tumorigenesisMaria A Kiskowski, Roger S Jackson, Jheelam Banerjee, et al.
Oncotarget|September 10, 2016
Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivoShu Yang, Ming Jiang, Magdalena M Grabowska, et al.
Cancer Research|November 17, 2005
Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancerMargaret S Joesting, Steve Perrin, Brian Elenbaas, et al.
The Journal of Urology|January 16, 2007
A preliminary study of JM-27: a serum marker that can specifically identify men with symptomatic benign prostatic hyperplasiaGrant W Cannon, Chris Mullins, M Scott Lucia, et al.
The Prostate|September 3, 2010
Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epitheliaBrigid Orr, Griet Vanpoucke, O Cathal Grace, et al.
Pageof 13